Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
AZD7687
Cat. No.:
OB0425LY-191
Appearance:
Solid
Purity:
99.8%
Identity:
Confirmed by LC-MS.
Size:
Add to basket
Product Overview
Description:
AZD7687 is a selective diacylglycerol acyltransferase 1 (DGAT1) inhibitor that inhibits human DGAT1.
Synonyms:
1166827-44-6; AZD-7687; AZD 7687; {4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid; 2-((1S,4S)-4-(4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl)cyclohexyl)acetic acid; 2-[4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl]acetic acid
CAS No.:
1166827-44-6
Compound CID:
42636350
Formula:
C21H25N3O3
Formula Weight:
367.44
Specification
Target:
Acyltransferase
Pathway:
Metabolic enzyme/Protease
Solubility:
DMSO
Storage:
Storage at -20°C.
Applications:
AZD7687 can be used in type 2 diabetes and obesity studies.
